Katyayani Tatiparti
Katyayani Tatiparti
Graduate Research Assistant
Verified email at wayne.edu
Title
Cited by
Cited by
Year
PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome
HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise, SK Kashaw, AK Iyer
Frontiers in pharmacology 8, 561, 2017
7372017
siRNA delivery strategies: a comprehensive review of recent developments
K Tatiparti, S Sau, SK Kashaw, AK Iyer
Nanomaterials 7 (4), 77, 2017
2122017
Advances in antibody–drug conjugates: a new era of targeted cancer therapy
S Sau, HO Alsaab, SK Kashaw, K Tatiparti, AK Iyer
Drug discovery today 22 (10), 1547-1556, 2017
1092017
Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers
KA Gawde, S Sau, K Tatiparti, SK Kashaw, M Mehrmohammadi, AS Azmi, ...
Colloids and Surfaces B: Biointerfaces 167, 8-19, 2018
452018
A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy
S Sau, K Tatiparti, HO Alsaab, SK Kashaw, AK Iyer
Drug discovery today 23 (7), 1344, 2018
162018
Copper-free ‘click’chemistry-based synthesis and characterization of carbonic anhydrase-IX anchored albumin-paclitaxel nanoparticles for targeting tumor hypoxia
K Tatiparti, S Sau, KA Gawde, AK Iyer
International journal of molecular sciences 19 (3), 838, 2018
142018
Review on self micro emulsifying drug delivery systems
S Reddy, T Katyayani, A Navatha, G Ramya
Int J Res Pharm Sci 2 (3), 382-92, 2011
142011
LIPOSOMES – THE FUTURE OF FORMULATIONS
M Sivasankar, K Tatiparti
INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY 1 (2), 259-267, 2011
72011
Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: using nanoparticles to overcome multidrug resistance
K Vanamala, K Tatiparti, K Bhise, S Sau, MH Scheetz, MJ Rybak, D Andes, ...
Drug Discovery Today, 2020
52020
Carbonic Anhydrase-IX Guided Albumin Nanoparticles for Hypoxia-mediated Triple-Negative Breast Cancer Cell Killing and Imaging of Patient-derived Tumor
K Tatiparti, MA Rauf, S Sau, AK Iyer
Molecules 25 (10), 2362, 2020
22020
A Biomimetic Drug Delivery System Targeting Tumor Hypoxia in Triple-Negative Breast Cancers
K Tatiparti, MA Rauf, S Sau, AK Iyer
Applied Sciences 10 (3), 1075, 2020
22020
Tumor multicomponent targeting nanoparticle library for personalized cancer therapy & imaging
S Sau, H Alsaab, K Tatiparti, K Bhise, A Rishi, AK Iyer
Cancer Research 78 (13 Supplement), 4660-4660, 2018
12018
Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas
T Koneru, E McCord, S Pawar, K Tatiparti, S Sau, AK Iyer
ACS omega, 2021
2021
LDL receptors and their role in targeted therapy for glioma: a review
S Pawar, T Koneru, E McCord, K Tatiparti, S Sau, AK Iyer
Drug Discovery Today, 2021
2021
Folate Receptors’ Expression in Gliomas May Possess Potential Nanoparticle-Based Drug Delivery Opportunities
E McCord, S Pawar, T Koneru, K Tatiparti, S Sau, AK Iyer
ACS omega 6 (6), 4111-4118, 2021
2021
Nano‐therapeutic strategies to target coronavirus
MA Rauf, M Tasleem, K Bhise, K Tatiparti, S Sau, AK Iyer
View, 20200155, 2021
2021
Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's
K Tatiparti, S Sau, MA Rauf, AK Iyer
DRUG DISCOVERY TODAY 25 (12), 2110-2129, 2020
2020
Smart treatment strategies for alleviating tauopathy and neuroinflammation to improve clinical outcome in Alzheimer's disease
K Tatiaparti, S Sau, MA Rauf, AK Iyer
Drug Discovery Today, 2020
2020
Hypoxia penetrating ultra-small nanoparticle for anti-cancer effect in Glioblastoma
MA Rauf, K Tatiparti, S Sau, AK Iyer
Cancer Research 80 (16 Supplement), 1721-1721, 2020
2020
Ultra‐Small Biomimetic Nanoparticles for Alzheimer’s Disease Targeted Drug Delivery
K Tatiparti, MA Rauf, S Sau, R Alzhrani, A Iyer
The FASEB Journal 30 (S1), 1-1, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20